Laser zaps painful sinus: new hope for faster recovery
NCT ID NCT07260643
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a minimally invasive laser technique called SiLaC for treating pilonidal sinus, a painful condition near the tailbone. Forty adults will receive the laser procedure, which aims to destroy the sinus tract and speed up healing. Researchers will track how quickly patients return to normal activities and monitor for complications or recurrence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Laser (1470-nm diode laser radial fiber)
What this could lead to
If successful, this laser technique could offer a faster, less painful recovery for people with pilonidal sinus, reducing the need for more invasive surgery.
What could go wrong
This is a small, early-stage study with only 40 participants and no comparison group. The procedure may not work for everyone, and recurrence or complications are still possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PILONIDAL SINUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••